4.6 Review

Transcatheter aortic valve implantation (TAVI): Valve design and evolution

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 168, Issue 3, Pages 1822-1831

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2013.07.117

Keywords

Aortic stenosis; Transcutaneous aortic valve implantation; Transcatheter aortic valve implantation; Percutaneous aortic valve replacement; Prosthetic valves

Funding

  1. The Prince Charles Hospital Foundation (TPCHF)
  2. University of Queensland (UQ)
  3. Office of Health and Medical Research (OHMR)

Ask authors/readers for more resources

The efficacy of transcatheter aortic valve implantation (TAVI) in high surgical risk and inoperable patients with severe aortic stenosis (AS) is rapidly gaining credibility with an ever-expanding body of supporting evidence. The potential of TAVI to be a treatment option for a significant cohort of patients with aortic stenosis has fuelled a drive for the optimum device and resulted in exponential advances in the technology with a focus on adverse event minimization and procedural simplification. Consequently, a plethora of new transcatheter valve choices are nowavailable for clinical study or in the pipeline. The evaluation of past, current and emerging devices allows for an appreciation of the design considerations involved in this process and an insight to the future direction of the technology. Crown Copyright (C) 2013 Published by Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available